The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-hexyl-4-methyl-2-oxo-2H-chromen-7-yl sulfamate ID: ALA4520442
PubChem CID: 155542123
Max Phase: Preclinical
Molecular Formula: C16H21NO5S
Molecular Weight: 339.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCc1c(C)c2ccc(OS(N)(=O)=O)cc2oc1=O
Standard InChI: InChI=1S/C16H21NO5S/c1-3-4-5-6-7-14-11(2)13-9-8-12(22-23(17,19)20)10-15(13)21-16(14)18/h8-10H,3-7H2,1-2H3,(H2,17,19,20)
Standard InChI Key: XSXHVGKWARQCCK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
11.4448 -2.4598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8575 -3.1697 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.2659 -2.4573 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3858 -3.5742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0911 -3.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6806 -3.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6831 -2.3543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9793 -1.9462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2726 -2.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2740 -3.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9783 -3.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7982 -3.5793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5671 -3.5809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1517 -3.5838 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0937 -2.3516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3858 -1.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3834 -1.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8027 -1.9453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5091 -2.3562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2181 -1.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9245 -2.3607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6335 -1.9544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3399 -2.3653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
7 16 1 0
6 4 1 0
4 5 1 0
5 15 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 12 2 0
10 13 1 0
13 2 1 0
2 14 1 0
15 16 2 0
16 17 1 0
15 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.41Molecular Weight (Monoisotopic): 339.1140AlogP: 2.81#Rotatable Bonds: 7Polar Surface Area: 99.60Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.65CX Basic pKa: ┄CX LogP: 3.35CX LogD: 3.35Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.62Np Likeness Score: -0.09
References 1. Zaraei SO, Abduelkarem AR, Anbar HS, Kobeissi S, Mohammad M, Ossama A, El-Gamal MI.. (2019) Sulfamates in drug design and discovery: Pre-clinical and clinical investigations., 179 [PMID:31255926 ] [10.1016/j.ejmech.2019.06.052 ]